though the specific functions of sleep have not been completely elucidated, the literature has suggested that sleep is essential for proper homeostasis. Sleep loss is associated with changes in behavioral, neurochemical, cellular, and metabolic function as well as impaired immune response. Using high-resolution microarrays we evaluated the gene expression profiles of healthy male volunteers who underwent 60 h of prolonged wakefulness (PW) followed by 12 h of sleep recovery (SR). Peripheral whole blood was collected at 8 am in the morning before the initiation of PW (Baseline), after the second night of PW, and one night after SR. We identified over 500 genes that were differentially expressed. Notably, these genes were related to DNA damage and repair and stress response, as well as diverse immune system responses, such as natural killer pathways including killer cell lectin-like receptors family, as well as granzymes and T-cell receptors, which play important roles in host defense. These results support the idea that sleep loss can lead to alterations in molecular processes that result in perturbation of cellular immunity, induction of inflammatory responses, and homeostatic imbalance. Moreover, expression of multiple genes was downregulated following PW and upregulated after SR compared with PW, suggesting an attempt of the body to re-establish internal homeostasis. In silico validation of alterations in the expression of CETN3, DNAJC, and CEACAM genes confirmed previous findings related to the molecular effects of sleep deprivation. Thus, the present findings confirm that the effects of sleep loss are not restricted to the brain and can occur intensely in peripheral tissues. gene expression; microarrays; sleep; sleep-wake cycle; sleep deprivation; immune system SLEEP CAN BE DIVIDED INTO two activity states in the mammalian brain: nonrapid eye movement (NREM) sleep and rapid eye moment (REM) sleep. Several roles of sleep in cellular network recovery and energy conservation, endocrine system organization, ecological and behavioral adaptations, learning, synaptic plasticity, and, most importantly, natural synaptic homeostasis maintenance have been hypothesized (62, 79, 86) . According to the homeostatic hypothesis, plasticity processes during wakefulness result in an increase in synaptic connections in the brain, and, therefore, the role of sleep would be to reduce synaptic potency to a baseline level that is energetically controllable (79, 80, 86) .
reduce synaptic potency to a baseline level that is energetically controllable (79, 80, 86) .
Sleep loss or deprivation is characterized by a complete absence of sleep during a certain period of time or a shorterthan-optimal sleep time. Chronic sleep loss is common in industrialized societies where the most frequent causes are those associated with contemporary lifestyle and work-related factors (81) . Lack of sleep has been shown to induce several behavioral, neurochemical, cellular, molecular, and metabolic alterations (2-4, 29, 81, 84) . It is known that glucose level change in metabolic syndrome and sleep deprivation has been strongly linked to glucose intolerance and hypertension, both associated with sleep apnea and consequently sleep deprivation (1) .
Gene expression is one of the fundamental mechanisms that control phenotype according to the need of a specific tissue or organ in a determined situation (72) . Thus, molecular biology and genomics tools are critical to understanding the molecular mechanisms involved in sleep and sleep deprivation. To date, the vast majority of the studies evaluating gene expression changes throughout the sleep-wake cycle, prolonged wakefulness (PW), and sleep recovery (SR) have been performed in different brain regions in various animal models (16, 26, 57, 58, 88) . Few studies have attempted to verify the effect of sleep loss in human volunteers (41) and since investigations have to be limited to measures that can be obtained from peripheral blood, the existing results are mainly related to immunological alterations (36) .
A bidirectional interaction between the peripheral blood and central nervous system has been demonstrated, with peripheral lymphocytes modulating the expression of hormones, cytokines, and neurotransmitters (23, 36, 55, 59, 93) . Classical evidence suggests that cytokine-to-brain communication occurs via the vagus nerve and sensory signals arriving via vagal afferents affecting cerebrocortical activity and sleep stages (12, 30) . The stimulus factors can alter vagal stimulation and define electroencephalogram synchronization or desynchronization followed by increases or decreases in the amounts of NREM and REM sleep (73) . Indeed, perturbations of the sleep-wake cycle have been shown to be involved in a large variety of medical conditions, such as diabetes mellitus, cardiovascular disease (14, 63, 65) , arthritis (82) , certain cancers (22, 46, 47) , and kidney dysfunction (33) , and are thought to be mediated by inflammatory molecules, as a result of pathogen recognition and activation of inflammatory cellular pathways (98) . This suggests that the effects of sleep loss are not restricted to the brain itself. Indeed, previous studies from our group demon-strated that PSD caused a significant reduction of circulating lymphocytes (25, 95) , a general decrease in all cellular subsets of spleen, mainly T and B cells (95) , as well as a decrease of total cellularity of the bone marrow and peripheral blood and a reduction in the absolute number of hematopoietic stem/progenitor cells and colony-forming units (25) . In this sense, the evaluation of peripheral blood has been shown to represent an attractive alternative to brain tissue analyses for gene expression studies in large-scale investigations of human volunteers (36, 41, 42) . Furthermore, this approach may provide insights into the neuroimmunological mechanisms involved in the regulation of sleep-wake cycle.
The present study is the first evaluation of the molecular effects of 48 h (collect point) of PW followed by a period of SR on the peripheral whole blood gene expression profile of healthy human volunteers. These results can help to establish the relevance of novel genes in the regulation of sleep-wake cycles; it can also help to identify the biological processes that occur in a particular sleep model.
METHODS
Subjects. Subjects were nine healthy human male volunteers ranging from 19 to 29 yr of age for each condition tested, summing up to a total of 27 independent observations. The sex selection was chosen mainly to avoid possible hormonal variations in females. In addition, sex can influence the transcriptional profiles, and a growing body of research has examined the modulation of brain dopaminergic systems by estrogen. The volunteers were carefully examined by trained physicians with the following exclusion criteria: engagement in shift work, presence of sleep disorders, extreme morningness or eveningness, history of neurological or psychiatric diseases and medical conditions, smoking, alcohol or substance abuse. These criteria were evaluated by validated questionnaires such as Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and the Beck Depression Inventory, as well as full-night polysomnography, a sleep diary, and actigraphy for a period of 1 wk before the protocol. Volunteers also underwent urine analysis to detect amphetamine, methamphetamine, cocaine, tetrahydrocannabinol, barbiturates, opiates, and benzodiazepines. More details of the study protocol can be found in our previous study (60) . The study was conducted at the Sleep Laboratory of the Department of Psychobiology at the Universidade Federal de São Paulo and was approved by the local ethical committee (#1676/06). All subjects signed an informed consent form.
Experimental protocol of PW. All participants were instructed during the week preceding the study as well as during the study period not to use alcohol, chocolate, and caffeinated beverages and to maintain a standardized bedtime according to their common habits. All subjects had an adaptation night followed by a night of baseline polysomnography at the sleep laboratory. Sleep recordings were performed on a digital electroencephalogram acquisition system with Embla Digital A10 recording/amplifier and Somnologica software (Flaga, Reykjavik, Iceland). The sleep deprivation period started in the following evening after the baseline night. Thus, subjects were kept awake for a total of 60 h (2 consecutive nights) and the following day after the second night of PW. PW was carried out through continuous vigilance of the volunteers by our technical staff and no any major physical activity was allowed. In summary, the volunteers were kept distracted reading books, watching TV, accessing the internet, and playing video-games to help them stay awake. To be consistent throughout the protocol, the blood collection was performed in the morning, and therefore the gene expression profiles of the PW period correspond to the time point of 48 h of wakefulness. The volunteers were allowed to sleep at the following night after the second night of PW (12 h SR opportunity), as summarized in Fig. 1 . The mean Ϯ SD total sleep time on the recovery night was 10:25 Ϯ 00: 19 .
Blood collection and sample preparation for microarrays. A total of two PAXgene tubes (PreAnalytiX, Hombrechtikon, Switzerland) of peripheral blood from each volunteer were collected following the baseline night and in the morning at 8 AM after 48 h of PW and after the night of SR (following morning). After collection, the tubes were incubated at room temperature for 2 h to allow RNA stabilization and then stored at Ϫ80°C. RNA was extracted from whole blood with the PAXgene Blood RNA System Kit following the manufacturer's recommendation. The RNA quality was evaluated by 1.0% agarose gel, with ethidium bromide staining, and RNA concentrations were determined with a NanoDrop ND-8000 spectrophotometer (NanoDrop Technologies; THERMO scientific, Wilmington, DE). Depletion of globin transcripts and microarray protocol. Globin mRNA was removed using the GLOBINclear-Human kit (Ambion, Austin, TX), following the manufacturer's recommendations. Globin mRNA constitutes up to 70% of whole blood mRNA and can reduce the efficacy of the microarray assay by interfering with the detection of less abundant gene transcripts (53, 61, 74, 85, 90, 91) . RNA quality and integrity were checked with the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
A total of 2 g of RNA from each subject and time point was used to hybridize 27 independents sets of GeneChip Human Genome U133 Plus 2.0 arrays (Affymetrix, Santa Clara, CA), according to the manufacturer's protocol and following the best practice and highstandard criteria required. The RNA processing and microarrays experimental protocols were performed in the Molecular Core-Microarray Facility, São Paulo, Brazil.
Microarray data analysis. Gene expression values were obtained using the three-step robust multiarray average preprocessing method (37) , implemented in the Affy (Affymetrix, Santa Clara, CA) package from R/Bioconductor. The ComBat method (43) was applied prior to analysis to correct the data for undesirable experimental variation (or batch effect) caused by the different days in which the microarrays were processed. ComBat implements an empirical Bayes approach, which is commonly used in microarray analyses due to its ability to robustly handle high-dimensional data when sample sizes are small (43) .
RankProd statistical test (10) was performed for the selection of differentially expressed genes (DEGs) following a two-class paired design. RankProd is a nonparametric procedure that detects genes highly ranked in a number of lists. This rank-based feature makes the method robust against noise and can reduce the number of replicate experiments required to obtain reliable results (10) . Furthermore, it is an effective alternative for the identification of candidate genes in the study of complex phenotypes, as well as when altered expression of a given gene is expected in a subgroup of individuals due to both multilocus genetic heterogeneity and the stochastic nature of gene expression in multifactorial systems (11) . The P value cut-off was set at 0.01 and adjusted by use of the false discovery rate (7) .
In addition, the data were analyzed by the Gene Expression Dynamics Inspector (GEDI) method, which is based on a selforganizing map (SOM) algorithm and creates intuitive visualization of each sample expression profiles (19) . This tool creates a map in which each gene retains exactly the same position in the map of each sample and permits the comparison of individual profiles based on direct visual detection of transcriptome patterns. Inspection of GEDI maps allows a straightforward classification of the samples into subgroups without the aid of a clustering algorithm (19, 28) . We set a 20ϫ20 SOM grid and Pearson's Correlation of 0.01.
Functional analysis. Functional pathway, gene ontology, and network analyses of the differentially expressed gene lists were performed using Ingenuity Pathway Analysis (IPA) 6.3 (Ingenuity Systems, Mountain View, CA). The gene lists for the PW and SR conditions, in relation to the baseline condition, as well as the list of common genes between both comparisons, were mapped to its respective gene object (public annotation for genes) in the Ingenuity pathway knowledge base. These so-called focus genes were then used as a source for creating biological networks (relationship between genes), canonical pathways (established pathways) analysis, and biological functions. A score was assigned to each network in the dataset to estimate the significance of the network in the selected gene list. The IPA identifies the biological functions and/or diseases that were most significant in the data set and right-tailed Fisher's exact test was used to calculate a P value determining the probability that each biological function and/or disease assigned to that data set is due to random chance. The most significant transcripts are then grouped into canonical pathways. The significance of the association between the data set and the canonical pathway was measured in two ways: 1) A ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed; 2) a P value calculated by Fisher's exact test determining the probability that the association between the genes in the dataset and the canonical pathway is explained by chance alone.
RESULTS
Transcriptome analyses and molecular signature of PW and SR. We performed a set of oligonucleotide microarrays containing 54 ,675 transcripts to demonstrate the impact of sleep loss on global gene expression levels. The Venn diagram illustrates the intersection among the DEGs identified in the three comparisons (Fig. 2) .
Using highly stringent statistical parameters, we identified 144 DEGs in PW compared with baseline (PW ϫ Baseline), with the majority of 124 genes found to be downregulated after PW (86.1%) and the remaining 20 (13.9%) were upregulated. On the other hand, the majority of the 592 DEGs identified in SR condition compared with PW (SR ϫ PW) were upregulated (93.58%).The comparison between Baseline and SR condition (SR ϫ Baseline) revealed 135 DEGs, 121 (89.62%) of which were upregulated and 12 (10.38%) downregulated.
A total of 78 genes were found in common among PW ϫ Baseline and SR ϫ PW comparisons and may be considered the molecular signature of the effects of sleep loss in this study (Supplemental Table S1 ). 1 Interestingly, all of the shared genes show an opposite expression pattern in each comparison tested (e.g., a particular gene might be downregulated following PW and upregulated following SR). Conversely, the 59 common genes identified in SR ϫ PW and SR ϫ Baseline comparisons demonstrated the same directional expression pattern. A similar trend was observed for the 22 common genes between Baseline ϫ PW and Baseline ϫ SR DEGs lists, with few exceptions such as CLEC2B, PFDN4, CD69, MALAT1, POLR2K, and CENPK genes, which were downregulated after PW, and upregulated following SR, in contrast to both PW and Baseline values. Interestingly, these six genes were the only 1 The online version of this article contains supplemental material. Table S1 and Table1). Functions related to the immune response, in addition to canonical pathways related to natural killer (NK) cell signaling and cross talk between dendritic and NK cells, mitochondrial dysfunction, and oxidative phosphorylation, were most enriched after PW and SR periods. In an attempt to evaluate whether the volunteers were properly rested after one night of SR, we examined three outcome metrics [lapses, sleepiness before the psychomotor vigilance test (PVT), and sleepiness after PVT] available in Table 2 . The number of lapses were significantly higher in PW (mean ϭ 13.66, SD ϭ 11.42) than baseline (mean ϭ 0.666, SD ϭ 1.11; P ϭ 0.008), and this number returned to baseline values after SR (mean ϭ 0.888, SD ϭ 1.69; P ϭ 0.008 vs. PW and P ϭ 0.892 vs. baseline). These objective measurements of sleepiness demonstrated that the parameters were altered after PW and returned to the baseline after one night of sleep recovery opportunity. These data confirmed that one night of recovery was apparently enough to re-establish cognitive functions and may support our results, in which the majority of genes returned to baseline expression patterns. In addition, the period of SR activated a set of genes that was unique to the SR ϫ PW comparison, which resulted in the enrichment of the following pathways: the eukaryotic initiation factor 2-alpha (eIF2alpha) signaling, regulation of eIF4 and p70S6K signaling, protein ubiquitination, mTOR signaling, and neuregulin signaling.
The gene interaction network corroborated these pathways and functions. Figure 3 illustrates the top network enriched in PW and the interaction among the genes in that comparison. It was observed, for example, that the immune system, protein synthesis, metabolism, and repair system are affected during PW as well as after SR.
To better understand these findings, we performed analyses with the set of 78 common genes, using the GEDI tool, which created a map for each individual in each of the three conditions tested (Fig. 4) . The map images revealed the specific visual identity of each sample, serving as a molecular portrait. The afore mentioned significant differences between baseline and PW gene expression patterns as well as the similarity between SR and baseline are immediately detected by visual inspection. In addition, the GEDI maps suggested that individuals 4, 6, 7, and 9 showed a more pronounced effect of the PW (clear distinct visual pattern of the PW condition compared 
DISCUSSION
The present study used microarrays to examine the molecular signatures associated with sleep deprivation and recovery. The study of global gene expression by microarrays has been shown to be useful in identifying candidate genes and associated molecular pathways in a variety of complex phenotypes (5, 6, 15, 27, 56 -58, 72) . Indeed, the literature is populated with extensive data about the molecular effects of sleep-related states in different brain regions of animal models (15, 58, 64, 88) . However, in humans, due to technical limitations in assessing brain tissue, the evaluation of peripheral total blood or specific cell lines has emerged as an interesting and readily available source for studying gene expression profiles (64) .
Several differentially expressed genes were recognized to be related to the immune system, cell death, protein processes, endoplasmatic reticulum (ER), and homeostasis in whole blood of volunteers subjected to a protocol consisting of PW and SR periods. Likewise, we explored several relevant genetic pathways. The majority of the differentially regulated genes were grouped into specific inflammatory regulation and immune system pathways following PW, which corroborates previous findings reported by our group on the immune effects of sleep deprivation (25, 75, 76, 95) . More specifically, after 60 h of PW, we detected the downregulation of several genes involved in NK-like receptors repertory and in the cross talk between NK cells and dendritic cell response. The NK family is known to play a role in mediating natural resistance against tumors and infections (87), while the cross talk between NK cells and dendritic cells is required for optimal immune cell expansion, activation of proinflammatory cytokines, and stimulation of T-cell responses (89) . In addition, the gene that encodes a T-cell receptor (TR delta receptor gene), responsible for rec- ognizing antigens bounded to major histocompatibility complex, was also downregulated after PW, followed by a significant upregulation after SR. Consistent with these findings, other groups have previously reported increased disease susceptibility, as a result of reduced immune system response, accompanied by a decline of cellular immunity molecules, such as NK receptors (20, 40, 77, 92) . Moreover, increased T-cell activity and a 30% lower NK count in the blood were demonstrated in people sleeping Ͻ7 h compared with a regular night's sleep (7-9 h) in a study evaluating the effects of short natural sleep time on both T-cell receptors and NK repertory (20) . Additionally, studies examining host resistance to viral infection and vaccine responses have also linked lack of sleep and immunological alterations (8, 9, 18, 39, 51, 75) . Spiegel et al. (78) showed that volunteers whose sleep was restricted to 4 h a night for six nights had less than half the immune response when vaccinated for influenza compared with the controls who had not been sleep deprived. Additionally, Irwin et al. (41) demonstrated that only one night (11 PM-3 AM) of restricted sleep significantly reduced white blood cell activity and induction of inflammatory molecules. Together with our data, these findings support the concept that adequate amounts of sleep are necessary to preserve the immune responses. In addition, the slight increase in expression of the TCR delta and NK-like receptors pathways during SR in our subjects and the inversion of the global gene expression pattern between PW and SR may indicate the body's attempt to re-establish the basal activity of these molecules and, consequently, the homeostatic equilibrium.
Additionally, the pathway analysis also revealed interesting results in the unique genes altered after SR process, compared with PW. The following pathways were most enriched in this analysis: eIF2alpha signaling, regulation of eIF4 and p70S6K signaling, protein ubiquitination, mTOR signaling, and neuregulin signaling. The eIF2alpha signaling pathway is associated with molecular signals that designate activation of the unfolded protein response (UPR) pathway, as a result of the accumulation of misfolded proteins in the ER (67, 70, 71, 97) . The UPR inhibits protein shipment by upregulating the expression of ER chaperones such as binding immunoglobulin protein and glucose-regulated protein 78, as well as attenuating protein translation through the phosphorylation of eIF2alpha (70, 71) . This pathway was already correlated to the protection of brainstem motoneurons in a murine model of intermittent hypoxia present in sleep apnea events (97) , which corroborates the findings in our data. Additionally, we found that the conserved serine/threonine kinase mTOR (the mammalian target of rapamycin) activates S6K1 and 4EBP1, which are involved in mRNA translation. The mTOR signaling pathway is activated by diverse stimuli, such as growth factors, nutrients, and energy and stress signals, and it was previously associated to hypoxia and sleep (94) . The neuregulin signaling pathway has been implicated in neurodevelopmental processes such as myelination and neuronal migration, as well as in the development of schizophrenia (13) . Although this specific pathway has not been associated with sleep-related phenotypes, the importance of these genes in brain and neuronal plasticity (54) suggests a possible role of the neuregulin signaling pathway in sleep homeostasis.
Moreover, our in silico validation of centrin-3 (CETN3), DnaJ (Hsp40), homolog C (DNAJC), and carcinoembryonic antigen-related cell adhesion molecule (CEACAM) genes confirmed other findings evaluating the molecular effects of sleep deprivation, sleep apnea, and ER stress processes involving protein folding (38, 45, (55) (56) (57) (58) . The CETN3 gene encodes a member of the centrin protein family. Transcript level changes of the CETN3 gene were demonstrated between wakefulness and sleep in a study evaluating a quantitative trait locus (QTL) previously identified as a genomic region on chromosome 13. This region was defined as the delta power in slow-wave sleep (or Dps1) (21, 56) . In this sense, although the role of the CETN3 gene in sleep remains to be elucidated, its location in a potential regulatory region of sleep homeostasis and the fact that this gene was identified as differentially expressed after sleep deprivation in two independent studies suggest that this finding deserves further evaluation. In the same line, the upregulation of DNAJC1 gene, a member of the heat shock family of proteins, which acts in the ER and is responsible for protein folding and molecular chaperone functions, has been previously identified as differentially expressed in cerebral cortex of mice and rats during wakefulness (56, 66 -69) . Accordingly, previous studies have consistently demonstrated that PW leads to perturbations that alter ER homeostasis (66 -69) . These alterations therefore disturb protein folding and lead to an increase in unfolded proteins and protein aggregates, which are detrimental to cell survival (66 -69) . As an escape process, the cell attempts to adapt, promoting a synchronized response to limit accumulation of unfolded proteins in the ER, which corroborates with the upregulation of heat shock proteins after a period of sleep loss found in the present study. It is worthwhile to mention that this alternative mechanism of stress is not cortisol-related. Indeed, our study supports this idea since the subjects' cortisol level measurements did not increase following PW (60) . Finally, CEACAM family genes have already been associated with sleep phenotypes in a previous study (45) , which serves as a further in silico validation of our findings. Khalyfa et al. (45) demonstrated that members of the CEACAM family, such as CEACAM1, CEACAM5, and CEACAM6, were upregulated in tonsillar tissues from sleep apnea patients with adenotonsillar hypertrophy, and proposed this gene family as a potential candidate in the molecular mechanisms underlying this sleep disorder.
Although sleep deprivation itself is distinct from obstructive sleep apnea (OSA), they have a myriad of overlapping effects in common such as metabolic alterations, oxidative stress, inflammation, and perturbation of immune system, as demonstrated by previous studies (35, 41, 44) . In addition, shared molecular capacities such as sympathetic activation, oxidative stress, and inflammation are affected in both situations, and, therefore, it is reasonable to think that common genes may be influenced as a result of OSA and sleep deprivation. However, it is important to mention that, despite the overlapping effects, OSA presents independent mechanisms for causing sleep fragmentation and therefore differs from isolated sleep deprivation. CEACAMs are part of a group of mammalian immunoglobulin-related glycoproteins. They are involved in cell recognition, modulation of tissue architecture, regulation of T-cell proliferation, and a pivotal key marker in cancer progression (48) . In the present study, the upregulation of CEACAM6 and 8 was observed after PW and remained altered following the SR period. Structurally, both proteins share close homology and functionality and have been implicated in cell adhesion, metastatic behavior of tumor cells such as leukemia and gastric cancer, and bone marrow disorder such as myelofibrosis (31, 52, 96) . Taken together, these findings imply a potential link between shorter sleep duration and increased risk of developing different types of cancer (32, 48) .
To be considered a sleep regulatory substance, a number of criteria should be met (17) , and, to date, only interleukin 1, tumor necrosis factor, growth hormone releasing hormone, prolactin, and nitric oxide have been described as having all the required characteristics. In this sense, it is important to note that we cannot affirm that the genes identified in this study are real regulatory markers, rather that the findings of the present study provide an overview of the direct effects of sleep loss on the gene expression profile of a peripheral tissue and of the potential biological markers and pathways, which should be validated in further studies.
The graphs generated by the GEDI program illustrated the differences between the global expression pattern of individuals in baseline and PW conditions and the similarity between SR and baseline conditions. They also showed different individual responses for a similar condition tested, an effect we expected since sleep deprivation is a complex process and known to affect individuals differently (24, 83) . It has been demonstrated that there are considerable individual differences in cognitive performance deficits resulting from shift work schedules as well in sleep electroencephalography (EEG) readings (49, 50) . Evidence suggests that individual sleep EEG patterns in NREM sleep and REM sleep are heritable traits. As an example, multiple recordings in the same individuals, as well as studies in monozygotic and dizygotic twins, suggest that a very high percentage of the robust interindividual variation and the high intraindividual stability of sleep EEG profiles can be associated with genetic factors (Ͼ90% in distinct frequency bands) (49, 50) . The molecular mechanisms of interindividual variation are essentially unknown, and the genetics and gene expression studies of normal sleep and SD are only beginning to be elucidated.
Sleep is important for repair in the brain and macromolecule biosynthesis, as well as for activities in peripheral tissue, such as the ones related to immune system regulation. Changes in gene expression between sleep and wakefulness, as revealed by different microarrays studies, have led us to a new understanding of the functions of sleep that will likely be the focus of future research in neuroscience. Nevertheless, we believe that sleep and SD can affect distinct peripheral tissues and are not restricted to the brain, as previously suggested (34) .
Due to the low amounts of RNA obtained from blood tissue after the globin reduction treatment, an important limitation of this study is the lack of validation of the findings with an independent technique. Nevertheless, a total of 78 genes were found in common between the Baseline ϫ PW and PW ϫ SR comparisons. The fact that these genes were identified in two independent analyses and were significantly expressed in opposite directions may be seen as a cross-validation of the presented findings. Moreover, in silico validation was provided for CETN3, DNAJ1, and CEACAM genes. Finally, in attempt to reduce the false-positive findings rate, we choose robust statistical analysis methods to establish the DEGs with stringent statistical correction. In this sense, it is clear that additional studies will be necessary to fully validate the potential candidate genes and functional network identified. However, the present results should open new frontiers regarding the evaluation of gene expression profiles in sleep medicine, as well as motivate further investigations to define the molecular effects of PW in humans.
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